- Home
- App Analytics
- DreamClear
DreamClear app analytics for December 11
DreamClear
- Somnomed Technologies Inc.
- Apple App Store
- Free
- Medical
DreamClear is a clinical level home sleep test app which is paired with a sensor interface module to conduct a patient sleep test at their home. The data from the app is then uploaded to our cloud and evaluated by a licensed and trained sleep physician in order to evaluate and provide treatment options for a patient with sleep disorders.
Our application / device pairing requires a BLE MTU size of 512, we find that IOS devices that do not support this larger payload size will not function with our device / app properly and as such we provide a message to the user stating that the device is not compatible"
Several older Apple devices are still support new iOS versions, but have this limitation with MTU size.
Like several iPad devices might have been in our unsupported device list, but it can support a latest iOS version 13 and above.
You can find our unsupported device list as below:
iPhone devices above then "iPhone 6s Plus"
iPad devices above then "iPad (7thGeneration)"
iPad Air devices above then "iPad Air 2"
iPad mini devices above then "iPad mini 4"
iPad Pro devices above then "iPad Pro(10.5-inch)"
Store Rank
The Store Rank is based on multiple parameters set by Google and Apple.
All Categories in
United States--
Medical in
United States--
Create an account to see avg.monthly downloadsContact us
DreamClear Ranking Stats Over Time
Similarweb's Usage Rank & Apple App Store Rank for DreamClear
Rank
No Data Available
DreamClear Ranking by Country
Counties in which DreamClear has the highest ranking in its main categories
No Data to Display
Top Competitors & Alternative Apps
Apps with a high probability of being used by the same users, from the same store.
Millennium CareConnect
Millennium Physician Group, LLC
COPC MyChart
Central Ohio Primary Care Physicians, Inc.
Lee Health Connect
Lee Memorial Hospital
eXciteOSA®
Signifier Medical Technologies Limited
DreamClear VS.
December 11, 2024